Caitong International Asset Management Co., LTD Intellia Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 7,892 shares of NTLA stock, worth $75,447. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,892
Previous 15,216
48.13%
Holding current value
$75,447
Previous $177 Million
68.37%
% of portfolio
0.04%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.4MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$124 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$103 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$91.8 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$43.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$36.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $727M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...